+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prevalence of dystrophic epidermolysis bullosa in Spain: a population-based study using the 3-source capture-recapture method. Evidence of a need for improvement in care



Prevalence of dystrophic epidermolysis bullosa in Spain: a population-based study using the 3-source capture-recapture method. Evidence of a need for improvement in care



Actas Dermo-Sifiliograficas 104(10): 890-896



Dystrophic epidermolysis bullosa (DEB) is a rare disease that represents a heavy burden for both the patient and the health care system. There are currently no data on the prevalence of DEB in Spain. To determine the prevalence of DEB in Spain. We used data from 3 incomplete population-based sources (hospital dermatology departments, diagnostic laboratories performing antigenic mapping, genetic testing or both, and the Spanish Association of Epidermolysis Bullosa Patients [DEBRA]) and combined them using the 3-source capture-recapture methodology. We identified 152 living DEB patients. The estimated prevalence of DEB was 6.0 cases per million (95% CI, 4.2-11.8) in adults and 15.3 (95% CI, 10.4-40.8) in children under 18 years of age. The data indicated that 77% of the patients were not being followed up in specialized centers of reference; 65% had not had a genetic diagnosis, and 76% were not members of DEBRA. The prevalence of DEB in Spain is 6.0 patients per million (95% CI, 4.2-11.8), a figure higher than previous estimates in many areas, but similar to those found in other southern Europe countries. The north-south difference may represent real geographic differences in prevalence, but it might be due to the fact that most of the data come from registries with a lower than expected catchment. Many patients are not being followed up in centers of reference, do not have genetic diagnosis, and are not members of patients' associations, suggesting that there is room for considerable improvement in their care.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055157427

Download citation: RISBibTeXText

PMID: 23809583

DOI: 10.1016/j.ad.2013.03.006


Related references

Prevalence of Dystrophic Epidermolysis Bullosa in Spain A Population-Based Study Using the 3-Source Capturea Recapture Method Evidence of a Need for Improvement in Care. 2013

Prevalence of autosomal recessive congenital ichthyosis: a population-based study using the capture-recapture method in Spain. Journal of the American Academy of Dermatology 67(2): 240-244, 2012

The international dystrophic epidermolysis bullosa patient registry: an online database of dystrophic epidermolysis bullosa patients and their COL7A1 mutations. Human Mutation 32(10): 1100-1107, 2011

Epidemiology of Inherited Epidermolysis Bullosa Based on Incidence and Prevalence Estimates From the National Epidermolysis Bullosa Registry. JAMA Dermatology 152(11): 1231-1238, 2016

Prevalence of chronic pain with or without neuropathic characteristics in France using the capture-recapture method: a population-based study. Pain 159(11): 2394-2402, 2018

An incompletely penetrant novel mutation in COL7A1 causes epidermolysis bullosa pruriginosa and dominant dystrophic epidermolysis bullosa phenotypes in an extended kindred. Pediatric Dermatology 29(6): 725-731, 2013

Epidemiology of inherited epidermolysis bullosa in Romania and genotype-phenotype correlations in patients with dystrophic epidermolysis bullosa. Journal of the European Academy of Dermatology and Venereology 29(5): 899-903, 2015

A rare complication of hereditary epidermolysis bullosa: esophageal carcinoma in recessive dystrophic epidermolysis bullosa inversa. European Journal of Dermatology 22(3): 409-410, 2012

Lack of efficacy of phenytoin in recessive dystrophic epidermolysis bullosa. Epidermolysis Bullosa Study Group. New England Journal of Medicine 327(3): 163-167, 1992

Epidermal aspects of type VII collagen: Implications for dystrophic epidermolysis bullosa and epidermolysis bullosa acquisita. Journal of Dermatology 45(5): 515-521, 2018

Proteases are responsible for blister formation in recessive dystrophic epidermolysis bullosa and epidermolysis bullosa simplex. British Journal of Dermatology 112(5): 533-538, 1985

Autosomal recessive epidermolysis bullosa simplex. Generalized phenotypic features suggestive of junctional or dystrophic epidermolysis bullosa, and association with neuromuscular diseases. Archives of Dermatology 125(7): 931-938, 1989

Epidermolysis bullosa nevus in a patient with recessive dystrophic epidermolysis bullosa: a case report. American Journal of Dermatopathology 36(12): E194-E197, 2014

Junctional epidermolysis bullosa incidence and survival: 5-year experience of the Dystrophic Epidermolysis Bullosa Research Association of America (DebRA) nurse educator, 2007 to 2011. Pediatric Dermatology 31(2): 159-162, 2015

Dilated cardiomyopathy in dystrophic epidermolysis bullosa: a lethal complication of epidermolysis bullosa. European Journal of Anaesthesiology 19(9): 689-690, 2002